TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
DMAC

DiaMedica Therapeutics Inc

Healthcare · Biotechnology

7.30$ +6.0% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow DMAC
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-1,139.2%
3.0%
124.0%
131.8%
-127.2%
10.0%
-10.0%
0.0%
4,243.2%
-1.0%
4,243.2%
3,094.0%
-1,149.2%

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?